Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen after COVID-19 Omicron XBB.1.5 vaccination in Japan
jRCTs031230490Completed
- Sponsor
- Allm
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in adverse reaction to COVID-19 vaccine comparing Acetaminophen arm with Placebo arm (2 arms). Primary endpoint: Incidence of local and/or systemic side reactions within 7 days. Started Dec 2023; status: completed.
02
Drugs
acetaminophen
03
Conditions
adverse reaction to COVID-19 vaccine
Beyond the preview
Go deeper on jRCTs031230490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230490.